Hologic Inc. (HOLX) Share Price Today, Stock Analysis, Annual Report | Value Research Hologic Inc. (HOLX) - Get live share price today, stock analysis, price valuation, performance, fundamentals, market cap, share holding, financial report of US stocks.

Hologic Inc. (HOLX)

Download Stock Report

NASDAQ: HOLX

  • Price Change
  • Market Capitalisation market-capitalisation-info $19,493 Mln

  • 12 Month Earnings monthly-earning $753 Mln
  • Price to Earnings price-to-earning 26.18

Hologic Inc. (HOLX) Share Price

$70.21

As on 22-Sep-2023 16:00 EDT

up-down-arrow $0.140.20%

  • Prev Close info

    $70.07

  • Day's Openinfo

    $70.24

  • Today's Highinfo

    $70.60

  • Today's Lowinfo

    $69.88

  • Today's Volumeinfo

    1,203,887

Please wait...

Hologic Inc. (HOLX) Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Hologic (HOLX)
-6.15 -6.67 -13.78 11.64 2.54 11.23 13.29
S&P BSE Sensex
8.49 1.22 3.91 11.02 20.17 12.37 12.54
S&P BSE Healthcare
20.54 -0.92 10.55 20.23 12.28 12.24 11.52
As on 22-Sep-2023
2022
2021
2020
2019
2018
2017
2016
Hologic (HOLX)
-2.29 5.12 39.49 27.03 -3.84 6.56 3.70
S&P BSE Sensex
4.44 21.99 15.75 14.38 5.87 27.91 1.95
S&P BSE Healthcare
-12.10 20.87 61.45 -3.55 -5.89 0.49 -12.88

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Hologic Inc. (HOLX) Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart of Hologic Inc. (HOLX)

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Chairman, CEO & Pres

        Mr. Stephen P. MacMillan

        Chief Financial Officer

        Ms. Karleen M. Oberton

        Headquarters

        Marlborough, MA

        FAQs for Hologic Inc. (HOLX)

        The total asset value of Hologic Inc. (HOLX) stood at $ 10,404 Mln as on 31-Mar-23

        The share price of Hologic Inc. (HOLX) is $70.210000 (NASDAQ) as of 22-Sep-2023 16:00 EDT. Hologic Inc. (HOLX) has given a return of 2.54% in the last 3 years.

        Hologic Inc. (HOLX) has a market capitalisation of $ 19,493 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

        The P/B ratio of Hologic Inc. (HOLX) is 3.83 times as on 02-Jun-2023, a 0.36% premium to its peers’ median range of 2.82 times.

        The P/E ratio of Hologic Inc. (HOLX) is 26.18 times as on 02-Jun-2023, a 0.2% premium to its peers’ median range of 21.83 times.

        Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
        Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
        Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
        Step 4. Search for the Hologic Inc. (HOLX) and enter the required number of quantities and click on buy to purchase the shares of Hologic Inc. (HOLX).

        Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. wa

        The CEO & director of Mr. Stephen P. MacMillan. is Hologic Inc. (HOLX), and CFO & Sr. VP is Ms. Karleen M. Oberton.

        The promoters of Hologic Inc. (HOLX) have pledged 0% of the total equity as on Mar-23.

        Hologic Inc. (HOLX) Ratios
        Return on equity(%)
        14.8
        Return on capital employed(%)
        --
        Debt-to-equity ratio
        0.53
        Dividend yield(%)
        0

        Yes, TTM profit after tax of Hologic Inc. (HOLX) was $753 Mln.

        Edit peer-selector-edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap market-cap-information $19,492.56 Mln
        • Revenue (TTM)revenue-information $4,056.70 Mln
        • Earnings (TTM) earning-information $753.00 Mln
        • Cash date-information $2,582.20 Mln
        • Total Debt info $2,823.90 Mln
        • Insider's Holding 0.73%
        • Liquidity liquidity High
        • 52 Week range week-range $59.78 - 87.88
        • Shares outstanding share-outstanding 246,554,000
        • 10 Years Aggregate:

          CFO: $9,318.92 Mln

          EBITDA: $11,915.83 Mln

          Net Profit: $4,199.56 Mln

        About The Company

        • IPO Date 21-Jun-1990
        • Chairman, CEO & Pres Mr. Stephen P. MacMillan
        • Chief Financial Officer Ms. Karleen M. Oberton
        • Listing key-listing NASDAQ: HOLX
        • Country United States
        • Headquarters headquarters Marlborough, MA
        • Website website https://www.hologic.com
        • Business

          Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It...  operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. wa  Read more

        Demystifying Stocks.

        At Value Research, we believe it's best to understand investments before diving in. And since 1990, we've been doing exactly that – helping & guiding lakhs of Indians with their investing journey. Join the journey.

        Sign Up for Free
        demystifying-mutual-fund

        What can Value Research do for you?

        solidify-your-fundamentals
        Solidify your fundamentals

        Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.

        track-all-your-investments
        Track all your investments

        Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.

        get-guidance-from-our-experts
        Get guidance from our experts

        Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.

        get-access-to-exclusive-analytics
        Get access to exclusive analytics

        Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.

        Explore it yourself, for free

        Sign up and get access to:

        Unlimited access to advice from India's top experts

        The most comprehensive analysis of funds and stocks in India

        A holistic portfolio manager to help track all your investments easily

        And much more, like guides, tools, webinars, videos and eBooks.

        share-fund-plan-icon